SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    White RH.The epidemiology of venous thromboembolism.Circulation2003;107:I48.
  • 2
    Anderson FA Jr, Spencer FA.Risk factors for venous thromboembolism.Circulation2003;107:I916.
  • 3
    Goldhaber SZ, Bounameaux H.Pulmonary embolism and deep vein thrombosis.Lancet2012;379:183546.
  • 4
    Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al.Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.Ann Rheum Dis2010;69:19205.
  • 5
    Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al.Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.Circulation2003;107:13037.
  • 6
    Del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A.Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.Arthritis Rheum2003;48:183340.
  • 7
    Van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, et al.Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.Ann Rheum Dis2009;68:1395400.
  • 8
    Fox EA, Kahn SR.The relationship between inflammation and venous thrombosis: a systematic review of clinical studies.Thromb Haemost2005;94:3625.
  • 9
    Van der Poll T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, et al.Activation of coagulation after administration of tumor necrosis factor to normal subjects.N Engl J Med1990;322:16227.
  • 10
    Folsom AR, Lutsey PL, Astor BC, Cushman M.C-reactive protein and venous thromboembolism: a prospective investigation in the ARIC cohort.Thromb Haemost2009;102:6159.
  • 11
    Luxembourg B, Schmitt J, Humpich M, Glowatzki M, Dressler D, Seifried E, et al.Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: a focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).Thromb Haemost2009;102:66875.
  • 12
    Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL.Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?Arthritis Rheum2012;64:5361.
  • 13
    Matta F, Singala R, Yaekoub A, Najjar R, Stein PD.Risk of venous thromboembolism with rheumatoid arthritis.Thromb Haemost2009;101:1348.
  • 14
    Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ.Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study.BMC Med2011;9:1.
  • 15
    Johannesdottir SA, Schmidt M, Horvath-Puho E, Sorensen HT.Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study.J Thromb Haemost2012;10:81521.
  • 16
    Zoller B, Li X, Sundquist J, Sundquist K.Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.Lancet2012;379:2449.
  • 17
    Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y.The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.Ann Rheum Dis2013;72:11827.
  • 18
    Holmqvist M, Neovius M, Eriksson J, Mantel A, Wallberg-Jonsson S, Jacobsson LT, et al.Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.JAMA2012;308:13506.
  • 19
    Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, et al.Validation of rheumatoid arthritis diagnoses in health care utilization data.Arthritis Res Ther2011;13:R32.
  • 20
    White RH, Garcia M, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, et al.Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.Thromb Res2010;126:617.
  • 21
    Tagalakis V, Kahn SR.Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database.Pharmacoepidemiol Drug Saf2011;20:3047.
  • 22
    Deyo R, Cherkin D, Ciol M.Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.J Clin Epidemiol1992;45:6139.
  • 23
    Schneeweiss S, Seeger J, Maclure M, Wang PS, Avorn J, Glynn RJ.Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.Am J Epidemiol2001;154:85464.
  • 24
    Glynn RJ, Rosner B.Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.Am J Epidemiol2005;162:97582.
  • 25
    Rothman K, Greenland S, Lash T.Modern epidemiology. 3rd ed.Philadelphia:Lippincott Williams & Wilkins;2008.
  • 26
    Cox D.Regression models and life-tables.J R Stat Soc1972;34:187220.
  • 27
    Zoller B, Li X, Sundquist J, Sundquist K.Autoimmune diseases and venous thromboembolism: a review of the literature.Am J Cardiovasc Dis2012;2:17183.
  • 28
    Anderson FJ, Wheeler H.Physician practices in the management of venous thromboembolism: a community-wide survey.J Vasc Surg1992;16:70714.
  • 29
    Nicolaides AN, Irving D. Clinical factors and the risk of deep venous thrombosis. In: Nicolaides AN, editor.Thromboembolism: etiology, advances in prevention, and management.Baltimore (MD):University Park Press;1975. p.193204.
  • 30
    Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study.Arch Intern Med1991;151:9338.
  • 31
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III.Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.Arch Intern Med1998;158:58593.
  • 32
    Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.Arch Intern Med2002;162:12458.
  • 33
    Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, et al.Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).J Thromb Haemost2012;10:101925.
  • 34
    Schneeweiss S, Avorn J.A review of uses of health care utilization databases for epidemiologic research on therapeutics.J Clin Epidemiol2005;58:32337.
  • 35
    Korswagen LA, Bartelds GM, Krieckaert CL, Turkstra F, Nurmohamed MT, van Schaardenburg D, et al.Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort study.Arthritis Rheum2011;63:87783.
  • 36
    Makol A, Grover M, Guggenheim C, Hassouna H.Etanercept and venous thromboembolism: a case series.J Med Case Rep2010;4:12.